John C.R. Randle

2.3k total citations
47 papers, 1.9k citations indexed

About

John C.R. Randle is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, John C.R. Randle has authored 47 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 23 papers in Cellular and Molecular Neuroscience and 7 papers in Organic Chemistry. Recurrent topics in John C.R. Randle's work include Neuroscience and Neuropharmacology Research (17 papers), Ion channel regulation and function (13 papers) and Photoreceptor and optogenetics research (6 papers). John C.R. Randle is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Ion channel regulation and function (13 papers) and Photoreceptor and optogenetics research (6 papers). John C.R. Randle collaborates with scholars based in France, United States and Canada. John C.R. Randle's co-authors include Leo P. Renaud, Charles W. Bourque, George Ku, Trevor A. Day, J. Lépagnol, Hal M. Hoffman, Kimberly Straley, Greg Henkel, Jeffrey H. Stack and Kevin Beaumont and has published in prestigious journals such as The Journal of Immunology, The Journal of Physiology and Journal of Neurophysiology.

In The Last Decade

John C.R. Randle

47 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John C.R. Randle France	23	806	716	474	358	227	47	1.9k
Susanna M.O. Hourani United Kingdom	26	678 0.8×	483 0.7×	276 0.6×	299 0.8×	80 0.4×	56	2.0k
Anthony L. Albiston Australia	33	2.0k 2.5×	1.1k 1.6×	280 0.6×	159 0.4×	213 0.9×	72	4.4k
Michael L. McCaleb United States	31	1.1k 1.4×	821 1.1×	152 0.3×	610 1.7×	132 0.6×	72	2.9k
Klaus Dembowsky Germany	24	819 1.0×	445 0.6×	157 0.3×	774 2.2×	349 1.5×	53	2.8k
Zbigniew S. Herman Poland	24	648 0.8×	539 0.8×	129 0.3×	92 0.3×	249 1.1×	110	2.1k
Francisco J. López United States	28	618 0.8×	735 1.0×	358 0.8×	412 1.2×	59 0.3×	72	2.4k
Sandra Lechner United States	20	785 1.0×	553 0.8×	167 0.4×	89 0.2×	131 0.6×	27	1.8k
Stephen H. Buck United States	31	1.7k 2.1×	1.9k 2.6×	180 0.4×	151 0.4×	77 0.3×	73	2.7k
Abba J. Kastin United States	10	928 1.2×	1.2k 1.6×	89 0.2×	162 0.5×	112 0.5×	13	1.8k
William G. North United States	27	618 0.8×	425 0.6×	958 2.0×	394 1.1×	25 0.1×	102	2.0k

Countries citing papers authored by John C.R. Randle

Since Specialization

Citations

This map shows the geographic impact of John C.R. Randle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C.R. Randle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C.R. Randle more than expected).

Fields of papers citing papers by John C.R. Randle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C.R. Randle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C.R. Randle. The network helps show where John C.R. Randle may publish in the future.

Co-authorship network of co-authors of John C.R. Randle

This figure shows the co-authorship network connecting the top 25 collaborators of John C.R. Randle. A scholar is included among the top collaborators of John C.R. Randle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C.R. Randle. John C.R. Randle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jung, Kwan‐Young, Zhan-Guo Gao, John C.R. Randle, et al.. (2024). Chimeras Derived from a P2Y₁₄ Receptor Antagonist and UDP-Sugar Agonists for Potential Treatment of Inflammation. ACS Pharmacology & Translational Science. 7(10). 3255–3278. 3 indexed citations

Jung, Kwan‐Young, Zhan‐Guo Gao, John C.R. Randle, et al.. (2023). Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y ₁₄ Receptor Antagonists. Journal of Medicinal Chemistry. 66(13). 9076–9094. 15 indexed citations

Salmaso, Veronica, Kwan‐Young Jung, Qasim Shah, et al.. (2022). Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y₁₄R Antagonist. Journal of Medicinal Chemistry. 65(4). 3434–3459. 14 indexed citations

Bernardino, Liliana, Silvia Balosso, Teresa Ravizza, et al.. (2008). Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X₇ receptor‐mediated IL‐1β release. Journal of Neurochemistry. 106(1). 271–280. 66 indexed citations

Namchuk, Mark, John R. Pollard, Pamella J. Ford, et al.. (2007). (S)-1-((S)-2-{[1-(4-Amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2 R,3 S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an Orally Available Selective Interleukin (IL)-Converting Enzyme/Caspase-1 Inhibitor, Exhibits Potent Anti-Inflammatory Activities by Inhibiting the Release of IL-1β and IL-18. Journal of Pharmacology and Experimental Therapeutics. 321(2). 509–516. 250 indexed citations

Ravizza, Teresa, Silvia Balosso, Liliana Bernardino, et al.. (2006). Inactivation of Caspase‐1 in Rodent Brain: A Novel Anticonvulsive Strategy. Epilepsia. 47(7). 1160–1168. 141 indexed citations

Stack, Jeffrey H., Kevin Beaumont, Paul D. Larsen, et al.. (2005). IL-Converting Enzyme/Caspase-1 Inhibitor VX-765 Blocks the Hypersensitive Response to an Inflammatory Stimulus in Monocytes from Familial Cold Autoinflammatory Syndrome Patients. The Journal of Immunology. 175(4). 2630–2634. 163 indexed citations

Zeisel, Mirjam B., L. Neff, John C.R. Randle, et al.. (2004). Impaired release of IL-18 from fibroblast-like synoviocytes activated with protein I/II, a pathogen-associated molecular pattern from oral streptococci, results from defective translation of IL-18 mRNA in pro-IL-18. Cellular Microbiology. 6(6). 593–598. 7 indexed citations

Jimonet, Patrick, Georg Andrees Böhme, Alain Boireau, et al.. (2001). Bioisosteres of 9-Carboxymethyl-4-oxo-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent In Vivo AMPA antagonists with longer durations of action. Bioorganic & Medicinal Chemistry Letters. 11(2). 127–132. 9 indexed citations

10.

Jimonet, Patrick, Georg Andrees Böhme, Alain Boireau, et al.. (2000). 8-Methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-ones: Highly In vivo Potent and Selective AMPA Receptor Antagonists. Bioorganic & Medicinal Chemistry. 8(8). 2211–2217. 3 indexed citations

11.

Stutzmann, J.M., Georg Andrees Böhme, Alain Boireau, et al.. (2000). 4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 10(10). 1133–1137. 14 indexed citations

12.

Pratt, Jeremy, Patrick Jimonet, Georg Andrees Böhme, et al.. (2000). Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]indeno[1,2-e]pyrazin-8- and -9-carboxylic (acetic) acid AMPA antagonists. Bioorganic & Medicinal Chemistry Letters. 10(24). 2749–2754. 9 indexed citations

13.

Jimonet, Patrick, Alain Boireau, Dominique Damour, et al.. (1999). Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo. Bioorganic & Medicinal Chemistry Letters. 9(20). 2921–2926. 21 indexed citations

14.

Randle, John C.R., et al.. (1993). Allosteric potentiation by diazoxide of AMPA receptor currents and synaptic potentials. European Journal of Pharmacology Molecular Pharmacology. 247(3). 257–265. 17 indexed citations

15.

Randle, John C.R., et al.. (1992). Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution. European Journal of Pharmacology. 215(2-3). 237–244. 45 indexed citations

16.

Randle, John C.R., Jean-Louis Péglion, & Jean‐François Renaud. (1991). Inhibition of L-Type But Not T-Type Calcium Channel Current by a New Dihydropyridine Derivative, S11568. Journal of Cardiovascular Pharmacology. 17(2). 348–348. 5 indexed citations

17.

Randle, John C.R., Stéphane H. R. Oliet, & J. F. Renaud. (1991). Alkali cation permeability and caesium blockade of cromakalim‐activated current in guinea‐pig ventricular myocytes. British Journal of Pharmacology. 103(3). 1795–1801. 5 indexed citations

18.

Randle, John C.R.. (1990). Tetrabutylammonium induces a voltage-dependent block of kainate current in Xenopus oocytes injected with rat brain mRNA. Canadian Journal of Physiology and Pharmacology. 68(8). 1069–1078. 3 indexed citations

19.

Randle, John C.R., et al.. (1990). Ca2+Channel inhibition by a new dihydropyridine derivatives,S111568 and its enantiomers S12967 and S12968. European Journal of Pharmacology. 190(1-2). 85–96. 15 indexed citations

20.

Renaud, Leo P., Jack H. Jhamandas, Ruud M. Buijs, Wilfrid N. Raby, & John C.R. Randle. (1988). Cardiovascular input to hypothalamic neurosecretory neurons. Brain Research Bulletin. 20(6). 771–777. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact